162 related articles for article (PubMed ID: 1792655)
1. Pharmacology of thromboxane A2, prostacyclin and other eicosanoids in the cardiovascular system.
Müller B
Therapie; 1991; 46(3):217-21. PubMed ID: 1792655
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
Smith JB; Araki H; Lefer AM
Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
[TBL] [Abstract][Full Text] [Related]
3. Role of eicosanoids in the cardiovascular system.
Wennmalm A
Acta Physiol Pol; 1988; 39(4):217-24. PubMed ID: 3075407
[TBL] [Abstract][Full Text] [Related]
4. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.
Gryglewski RJ; Dembínska-Kieć A; Korbut R
Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254
[TBL] [Abstract][Full Text] [Related]
5. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes.
Li Y; Kang JX; Leaf A
Prostaglandins; 1997 Aug; 54(2):511-30. PubMed ID: 9380795
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
8. Role of prostacyclin in the cardiovascular response to thromboxane A2.
Cheng Y; Austin SC; Rocca B; Koller BH; Coffman TM; Grosser T; Lawson JA; FitzGerald GA
Science; 2002 Apr; 296(5567):539-41. PubMed ID: 11964481
[TBL] [Abstract][Full Text] [Related]
9. Vascular biology of eicosanoids and atherogenesis.
Praticò D; Dogné JM
Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1079-89. PubMed ID: 19764861
[TBL] [Abstract][Full Text] [Related]
10. Cellular activation by thromboxane A2 and other eicosanoids.
Reilly M; Fitzgerald GA
Eur Heart J; 1993 Dec; 14 Suppl K():88-93. PubMed ID: 8131796
[TBL] [Abstract][Full Text] [Related]
11. An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems.
Sharma S; Sharma SC
Indian J Exp Biol; 1997 Oct; 35(10):1025-31. PubMed ID: 9475035
[TBL] [Abstract][Full Text] [Related]
12. [Eicosanoids as mediators in ARDS].
Loick HM; Theissen JL
Anasthesiol Intensivmed Notfallmed Schmerzther; 1994 Feb; 29(1):3-9. PubMed ID: 8142566
[TBL] [Abstract][Full Text] [Related]
13. COX-2 inhibitors and metabolism of essential fatty acids.
Das UN
Med Sci Monit; 2005 Jul; 11(7):RA233-7. PubMed ID: 15990700
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis and pharmacological modulation of thromboxane in humans.
Patrono C
Circulation; 1990 Jan; 81(1 Suppl):I12-5; discussion I22-3. PubMed ID: 2136814
[TBL] [Abstract][Full Text] [Related]
15. Preliminary clinical studies with thromboxane synthase inhibitors and thromboxane receptor blockers. A review.
Fiddler GI; Lumley P
Circulation; 1990 Jan; 81(1 Suppl):I69-78; discussion I79-80. PubMed ID: 2136820
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats.
Larivière R; Moreau C; Rodrigue ME; Lebel M
Prostaglandins Leukot Essent Fatty Acids; 2004 Aug; 71(2):103-9. PubMed ID: 15207526
[TBL] [Abstract][Full Text] [Related]
17. Altered eicosanoid levels in human colon cancer.
Rigas B; Goldman IS; Levine L
J Lab Clin Med; 1993 Nov; 122(5):518-23. PubMed ID: 8228569
[TBL] [Abstract][Full Text] [Related]
18. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitroglycerin on human vascular prostacyclin and thromboxane A2 generation.
Mehta J; Mehta P; Ostrowski N
J Lab Clin Med; 1983 Jul; 102(1):116-25. PubMed ID: 6406630
[TBL] [Abstract][Full Text] [Related]
20. Can COX-2 inhibitor-induced increase in cardiovascular disease risk be modified by essential fatty acids?
Das UN
J Assoc Physicians India; 2005 Jul; 53():623-7. PubMed ID: 16190133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
